Imagion Biosystems Limited reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was AUD 0.690012 million compared to AUD 0.265763 million a year ago. Revenue was AUD 0.690012 million compared to AUD 0.265763 million a year ago.

Net loss was AUD 7.68 million compared to AUD 5.76 million a year ago. Basic loss per share from continuing operations was AUD 0.272 compared to AUD 0.204 a year ago. Diluted loss per share from continuing operations was AUD 0.272 compared to AUD 0.204 a year ago.